CLRI — what changed in the latest 10-Q
A section-by-section comparison of CLRI's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-12 vs the prior 10-Q · 2026-02-13
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +13 | −3 | ~9 | 11 |
| Controls & procedures | Text added/removed | +2 | −1 | 0 | 1 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Market risk (Item 3), Risk factors, Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-12
FOR THE SIX MONTHS ENDED MARCH 31, 2026 COMPARED TO THE SIX MONTHS ENDED MARCH 31, 2025
Revenues increased 24.08% to $2,386,041 for the six months ended March 31, 2026 as compared to $1,923,027 for the six months ended March 31, 2025. The primary reason for the increase was an increase in revenue from the ReadyOp and Alastar platforms from $1,731,576 in 2025 to $2,001,495 in 2026. Ther…
Cost of revenues increased 1.83% to $402,824 for the six months ended March 31, 2026 as compared to $395,589 for the six months ended March 31, 2025. The primary reason for the increase was due to an increase in ReadyOp and Alastar platform sales and expenses associated with trade show attendance an…
Operating expenses increased 7.99% to $1,748,194 for the six months ended March 31, 2026 compared to $1,618,831 for the six months ended March 31, 2025. The increase was primarily due to administrative expenses, with a slight offset in selling and research and development expenses. General and admin…
For the six months ended March 31, 2026, selling expenses were $86,709 compared to $117,990 for the six months ended March 31, 2025, a decrease of 26.51%. This decrease was primarily due to a decrease in advertising expense, travel expenses and offset by a recovery of credit losses.
Text removed vs the prior filing · source: 10-Q · 2026-02-13
For the three months ended December 31, 2025, net cash provided in operations of $147,634 was the result of a net income of $194,806, depreciation and amortization expense of $5,393, an increase of accounts receivable of $86,849. These were offset by a decrease in accounts payable of $43,900, a reco…
For the three months ended December 31, 2024, net cash used in operations of $164,714 was the result of a net loss of $49,125, depreciation and amortization expense of $5,483, amortization of operating lease of $5,983, an increase of accounts receivable of $70,019. These were offset by a decrease in…
Net cash used in investing activities was $1,613 and $0 for the three months ended December 31, 2025 and 2024, respectively, which was for the purchase of fixed assets.
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2026-05-12
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time period specified in …
Management has carried out an evaluation of the effectiveness of the design and operation of our company’s disclosure controls and procedures. Due to limited number of personnel, there are inherent challenges in achieving complete segregation of duties within the financial reporting process, managem…
Text removed vs the prior filing · source: 10-Q · 2026-02-13
An evaluation was conducted by the registrant’s Chief Executive Officer (CEO) and Chief Financial Officer (CFO) of the effectiveness of the design and operation of the registrant’s disclosure controls and procedures as of December 31, 2025. Based on that evaluation, the CEO and CFO concluded that th…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice